" "
Full Text (PDF)
Original Article

Role of low hemoglobin level in predicting response to neoadjuvant chemotherapy in breast cancer and its correlation with p53, bcl-2 and VEGF – a prospective clinical study

Chintamani* , Chintamani* J.P. Singh** Rohan Khandelwal*** Megha Tandon**** Usha Agarwal***** Sunita Saxena******

Author Information

Licence:



New Indian Journal of Surgery 1(1):p 13-21, . | DOI:
How Cite This Article:

Received : N/A         Accepted : N/A          Published : N/A

Abstract

Neo-adjuvant chemotherapy (NACT) is an integral part of multi-modality approach in the management of locally advanced breast cancer (LABC). It is required both for the local control (to ensure microscopically free margins during surgery) and distant or systemic control [1-6]. Development of resistance to chemotherapeutic agents is a major and evolving problem. Various markers like P-Glycoprotein, tumor suppressor gene p53, apoptotic markers( Bcl-2, Bax) have been studied to predict the response to NACT[1].

Key words: Hemoglobin, breast cancer, neoadjuvant, Chemotherapy.


References

No records found.


Funding


Author Information

Authors and Affiliatione

  • Chintamani*
    ,
  • Chintamani* J.P. Singh** Rohan Khandelwal*** Megha Tandon**** Usha Agarwal***** Sunita Saxena******
    ,

Conflicts of Interest

Supplementary Information

Below is the link to the supplementary material.


Rights and Permissions



About this article


Cite this article


Licence:



Download citation

Received Accepted Published
N/A N/A N/A
DOI:
Keywords

Article Level Metrics

Last Updated

Saturday 07 June 2025, 20:18:17 (IST)


3

Accesses

00
0
00

Citations


22
11
23

View full article metrics including social shares, article views and publishing history


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article




Share